A Multidisciplinary Approach to Standardizing Processes for Blinatumomab Administration

    loading  Checking for direct PDF access through Ovid

Abstract

Blinatumomab (Blincyto®) has received accelerated approval for treatment of relapsed or refractory acute lymphoblastic leukemia. This article describes the authors’ experi-ence with a multidisciplinary collaboration among nursing, pharmacy, prescribers, and support staff, which has proven to be key for safe administration. The approach can be applied to other institutions planning to use blinatumomab.

Related Topics

    loading  Loading Related Articles